NCT03091400 Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS) Status COMPLETED Phase PHASE2
NCT03087136 A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03073603 Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS) Status COMPLETED Phase PHASE4
NCT03069170 Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis. Status UNKNOWN Phase PHASE1
NCT03057652 Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training Status UNKNOWN Phase NA
NCT03052595 Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance Status COMPLETED Phase N/A
NCT03049969 Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS) Status TERMINATED Phase NA
NCT03047460 Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting Status COMPLETED Phase N/A
NCT03046251 Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT03045380 Effect of Video Game Based Physical Activity Training in Persons With Multiple Sclerosis Status COMPLETED Phase NA
NCT03033355 Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder Status COMPLETED Phase N/A
NCT03032601 Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis Status ENROLLING_BY_INVITATION Phase NA
NCT03029897 E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase NA
NCT03028675 pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress Status COMPLETED Phase N/A
NCT03025269 Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis Status COMPLETED Phase N/A
NCT03021317 Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses Status TERMINATED Phase PHASE4
NCT03005119 Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms Status UNKNOWN Phase PHASE2
NCT03004794 Characteristics and Predictors of Progression of an Egyptian Multiple Sclerosis Cohort Status COMPLETED Phase N/A